HomeIMR • FRA
add
AC Immune SA
Previous close
€2.66
Day range
€2.60 - €2.78
Year range
€1.24 - €3.32
Market cap
294.31M USD
Avg Volume
1.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 939.00K | -96.32% |
Operating expense | 3.57M | -4.47% |
Net income | -15.86M | -388.17% |
Net profit margin | -1.69K | -7,922.23% |
Earnings per share | -0.16 | -420.00% |
EBITDA | -15.36M | -301.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 108.47M | -31.30% |
Total assets | 171.61M | -29.74% |
Total liabilities | 109.16M | -4.31% |
Total equity | 62.44M | — |
Shares outstanding | 100.89M | — |
Price to book | 4.29 | — |
Return on assets | -21.69% | — |
Return on capital | -53.48% | — |
Cash Flow
Net change in cash
| (CHF) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -15.86M | -388.17% |
Cash from operations | -18.34M | -29.68% |
Cash from investing | 20.63M | 1,088.40% |
Cash from financing | -254.00K | -46.82% |
Net change in cash | 2.02M | 110.54% |
Free cash flow | -10.37M | 43.81% |
About
Founded
2003
Website
Employees
153
